RxDoctor Payments Data

Jesse Sergent, APRN

Family · Ashland, KYNPI 1215573647

Payments from drug & device makers

$2,447in general payments, 2019–2025

Across 127 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$638
  • Bayer$382
  • Travere Therapeutics, Inc.$278
  • Akebia Therapeutics Inc$185
  • Lilly USA, LLC$154
  • Vifor Pharma, Inc.$152
  • plus $657 from 14 others

What the payments were for

  • Food & beverage$2,35796%
  • Education$904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,447 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$26,691
Medicare patients
258
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tolvaptan11$21,816
FarxigaDapagliflozin Propanediol21$18,516
VeltassaPatiromer Calcium Sorbitex12$14,231
JardianceEmpagliflozin11$9,393
Potassium Chloride29$1,003
Calcitriol63$869
Nifedipine ErNifedipine14$620
Klor-Con M20Potassium Chloride13$585
Chlorthalidone16$318
Allopurinol52$318
Metoprolol Succinate11$287
Lisinopril40$280
Furosemide62$254
Hydralazine Hcl19$250
Amlodipine Besylate41$235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$141$18,51621 claims
Boehringer IngelheimJardiance$82$9,39311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →